SEGMENT REPORTING (Details) - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021
Operating loss	$ (4,759,000)	$ (4,499,000)
Assets	37,324,000		$ 40,574,000
Accounts receivable, net	469,000		357,000
Inventory	786,000		864,000
Interest expense	50,000.00	20,000.00
Depreciation and amortization	999,000	663,000
Impairment of goodwill	2,700,000	0
Total assets	37,324,000		40,574,000
Assets	(37,324,000)		$ (40,574,000)
Cure Operations [Member]
Net sales	40,000	194,000
Operating loss	(873,000)	(2,816,000)
Assets	44,450,000	45,767,000
Accounts receivable, net	0	151,000
Inventory	260,000	342,000
Interest expense	173,000	64,000
Depreciation and amortization	421,000	86,000
Impairment of goodwill	2,728	0
Total assets	44,450,000	45,767,000
Assets	(44,450,000)	(45,767,000)
Sera Labs Operations [Member]
Net sales	1,076,000	1,260,000
Operating loss	(1,158,000)	(1,674,000)
Assets	7,049,000	12,588,000
Accounts receivable, net	469,000	11,000
Inventory	526,000	461,000
Interest expense	23,000	3,000
Depreciation and amortization	578,000	577,000
Impairment of goodwill	0	0
Total assets	7,049,000	12,588,000
Assets	(7,049,000)	(12,588,000)
Eliminations [Member]
Net sales	(13,000)	(9,000)
Operating loss	0	0
Assets	14,175,000	14,175,000
Accounts receivable, net	0	0
Inventory	0	0
Interest expense	0	0
Depreciation and amortization	0	0
Impairment of goodwill	0	0
Total assets	14,175,000	14,175,000
Assets	(14,175,000)	(14,175,000)
Total [Member]
Net sales	1,103,000	1,445,000
Operating loss	(2,031,000)	(4,499,000)
Assets	37,324,000	44,180,000
Accounts receivable, net	469,000	268,000
Inventory	786,000	803,000
Interest expense	196,000	67,000
Depreciation and amortization	999,000	663,000
Impairment of goodwill	2,728	0
Total assets	37,324,000	44,180,000
Assets	$ (37,324,000)	$ (44,180,000)